January 17, 2018 / 7:19 AM / 8 months ago

BRIEF-Isofol Medical: Successful Regulatory Meeting With FDA

Jan 17 (Reuters) - ISOFOL MEDICAL AB:

* SUCCESSFUL END-OF-PHASE 2 MEETING WITH FDA AND PHASE 3 PROGRAM FOR MODUFOLIN® AGREED

* ‍HAS HAD SUCCESSFUL REGULATORY MEETING WITH US FDA, IMPORTANT MILESTONE IN REGULATORY PROCESS​

* ‍PHASE III STUDY, ISO-CC-007, IS EXPECTED TO BE COMPLETED BY 2020/2021​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below